TrialCancer science2020

Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study.

Naomi Kawashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.